Our first-of-its-kind AI agent identifies eligible patients in neurology trials with exceptional speed and precision. Paired with a novel predictive model, it goes further—predicting patients most likely to meet study goals, accelerating enrollment and increasing trial success rates.
We transform multimodal patient data—including clinical, molecular, genetic, imaging data, and more—into insights and intuitive queries to identify targets and accelerate therapeutic discovery.
Neurology’s first AI-powered clinical decision support system. Diagnose earlier, predict progression, and personalize treatment using integrated patient data.
We generate unique medical insights and centralize complex data, keeping you informed with the most accurate, up-to-date research.
Globally, more than 80% of trials get either delayed or terminated because of a lack of participants. Global data analysis of all terminated trials within Clinical Trials Database reported 55% of trials were terminated due to the single highest reason of low accrual rate.
Trial delays affect not just study costs but subsequent sales, causing potential losses as high as $8 million per day, according to a CenterWatch study
85% of patients were either unaware or unsure that participation in a clinical trial was an option at the time of diagnosis. 75% of these patients said they would have been willing to enroll had they known it was possible.
Medicine is rapidly advancing toward personalized care. In this new era, every stakeholder—patients, healthcare professionals, sponsors, and more—plays a vital role in ensuring that medical treatments are precisely tailored to each patient's unique health profile. With our unique approach, we are ideally positioned to lead the way in delivering this level of personalized care.